OGC
MRKR icon

One68 Global Capital’s Marker Therapeutics MRKR Stock Holding History

One68 Global Capital’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,500
Closed -$48K – 24
2020
Q1 		$48K Sell
2,500
-500
-17% -$12.7K 0.49% 8
2019
Q4 		$86K Hold
3,000
– – 0.19% 74
2019
Q3 		$153K Hold
3,000
– – 0.35% 14
2019
Q2 		$238K Hold
3,000
– – 0.3% 16
2019
Q1 		$198K Buy
+3,000
New +$175K 0.59% 15

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

One68 Global Capital's MRKR Position: Q2 2020 in Review

One68 Global Capital sold out of Marker Therapeutics (MRKR) in Q2 2020, closing a stake of 2,500 shares — an estimated $48K sold.

One68 Global Capital first reported a position in MRKR in Q1 2019 and held it in 5 quarters. The position peaked at $238K in Q2 2019. 63 funds tracked by Wall St. Rank hold MRKR as of Q2 2020.

  • One68 Global Capital reported no remaining Marker Therapeutics position as of Q2 2020 after selling out during the quarter.
  • One68 Global Capital sold 2,500 Marker Therapeutics shares in Q2 2020, an estimated $48K.
  • One68 Global Capital first reported a position in Marker Therapeutics in Q1 2019 and held it in 5 quarters.
  • One68 Global Capital's Marker Therapeutics position peaked at $238K in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2020.

Based on One68 Global Capital's 13F filing for Q2 2020, filed 13 Aug 2020.